• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET,EA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET,EA Back to Search Results
Catalog Number 12220
Device Problems Contamination (1120); No Apparent Adverse Event (3189)
Patient Problem Hypersensitivity/Allergic reaction (1907)
Event Date 06/30/2022
Event Type  malfunction  
Event Description
The customer reported that they received 'cells detected in plasma line in centrifuge' alarm for a therapeutic plasma exchange (tpe) procedure.The patient was on the machine for 10 minutes.The patient developed coughing and chest tightness when on the machine.The coughing and the chest tightness subsided about 15 min after taking off the machine.The alarm occurred about 8 or nine minutes into the run.There was fluid in the waste bag at this time.The plasma was orange tinged in the cassette.The procedure was discontinued per physician orders.No medical intervention was necessary.
 
Manufacturer Narrative
Investigation: a used optia set was returned for investigation.It was noted that blood warmer tubing was attached and returned with the set.The disposable set was visually evaluated for any mis-assembly, leak location, or defect that could have contributed to the reported incident with no anomalies observed.All pressure sensors were inspected and determined to be functioning properly.Gravity was used to manipulate fluid throughout the set and no fluid flow or line obstruction issues were noted.The lower hex was inspected for evidence of loading.The latch pin witness mark of the lower hex was identified adjacent to the red inlet tubing indicting the lower hex was loaded in the centrifuge collar holder in a less than optimal position, which could cause a plasma line occlusion.Investigation is in process, a follow-up report will be provided.
 
Manufacturer Narrative
Investigation: a used optia set was returned for investigation.It was noted that blood warmer tubing was attached and returned with the set.The disposable set was visually evaluated for any mis-assembly, leak location, or defect that could have contributed to the reported incident with no anomalies observed.All pressure sensors were inspected and determined to be functioning properly.Gravity was used to manipulate fluid throughout the set and no fluid flow or line obstruction issues were noted.The lower hex was inspected for evidence of loading.The latch pin witness mark of the lower hex was identified adjacent to the red inlet tubing indicting the lower hex was loaded in the centrifuge collar holder in a less than optimal position, which could cause a plasma line occlusion.Further evaluation of this event has determined that the device did not cause or contribute to a death or serious injury, nor is there a likely potential for death or serious injury associated with this event based on additional investigational information.It was confirmed through lab testing that this event was an rbc spillover, not hemolysis.No further reporting will be provided as this does not represent a reportable event.
 
Event Description
The customer reported that they received 'cells detected in plasma line in centrifuge' alarm for a therapeutic plasma exchange (tpe) procedure.The patient was on the machine for 10 minutes.The patient developed coughing and chest tightness when on the machine.The coughing and the chest tightness subsided about 15 min after taking off the machine.The alarm occurred about 8 or nine minutes into the run.There was fluid in the waste bag at this time.The plasma was orange tinged in the cassette.The procedure was discontinued per physician orders.No medical intervention was necessary.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA EXCHANGE SET,EA
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer (Section G)
TERUMO BCT
10810 w. collins ave
lakewood CO 80215
Manufacturer Contact
scot hilden
10810 w. collins ave
lakewood, CO 80215
MDR Report Key15078743
MDR Text Key296346305
Report Number1722028-2022-00239
Device Sequence Number1
Product Code GKT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
BK150251
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 07/21/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/02/2024
Device Catalogue Number12220
Device Lot Number2204013330
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/14/2022
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/30/2022
Initial Date FDA Received07/21/2022
Supplement Dates Manufacturer Received08/10/2022
Supplement Dates FDA Received08/15/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/02/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age52 YR
Patient SexMale
Patient Weight80 KG
-
-